BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35362548)

  • 1. MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells.
    Cao Y; Huang F; Liu J; Qi H; Xiao J
    Histol Histopathol; 2022 Sep; 37(9):879-888. PubMed ID: 35362548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
    Agarwal S; Behring M; Kim HG; Chandrashekar DS; Chakravarthi BVSK; Gupta N; Bajpai P; Elkholy A; Al Diffalha S; Datta PK; Heslin MJ; Varambally S; Manne U
    Mol Oncol; 2020 Dec; 14(12):3007-3029. PubMed ID: 33037736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.
    Zhang X; Zhou J; Xue D; Li Z; Liu Y; Dong L
    Int J Biol Macromol; 2019 May; 129():227-232. PubMed ID: 30685303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
    Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB
    J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX6 upstream antisense RNA (PAUPAR) inhibits colorectal cancer progression through modulation of the microRNA (miR)-17-5p / zinc finger protein 750 (ZNF750) axis.
    Wen R; Chen C; Zhong X; Hu C
    Bioengineered; 2021 Dec; 12(1):3886-3899. PubMed ID: 34288812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells.
    Rubie C; Kruse B; Frick VO; Kölsch K; Ghadjar P; Wagner M; Grässer F; Wagenpfeil S; Glanemann M
    J Transl Med; 2014 Feb; 12():48. PubMed ID: 24559209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1.
    Li K; Zhang J; Zhang M; Wu Y; Lu X; Zhu Y
    World J Surg Oncol; 2021 Feb; 19(1):54. PubMed ID: 33608020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
    Sheng N; Yan L; Wu K; You W; Gong J; Hu L; Tan G; Chen H; Wang Z
    Cell Death Dis; 2018 Mar; 9(3):402. PubMed ID: 29540729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells.
    Ding X; Fu Q; Chen W; Chen L; Zeng Q; Zhang S; He L
    Cell Biol Int; 2022 May; 46(5):840-848. PubMed ID: 35143103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3.
    Chen Q; Zhou L; Ye X; Tao M; Wu J
    Pathol Res Pract; 2020 Apr; 216(4):152872. PubMed ID: 32107086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-452-5p promotes colorectal cancer progression by regulating an ERK/MAPK positive feedback loop.
    Lin X; Han L; Gu C; Lai Y; Lai Q; Li Q; He C; Meng Y; Pan L; Liu S; Li A
    Aging (Albany NY); 2021 Mar; 13(5):7608-7626. PubMed ID: 33658394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
    Yan Y; Zhang D; Lei T; Zhao C; Han J; Cui J; Wang Y
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):928-936. PubMed ID: 31209892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aloperine Inhibits Proliferation and Promotes Apoptosis in Colorectal Cancer Cells by Regulating the circNSUN2/miR-296-5p/STAT3 Pathway.
    Han W; Kong D; Lu Q; Zhang W; Fan Z
    Drug Des Devel Ther; 2021; 15():857-870. PubMed ID: 33664565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
    Li S; Yan G; Liu W; Li C; Wang X
    Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Downregulating LDHB.
    Zhang D; Yang N
    J BUON; 2019; 24(3):1128-1136. PubMed ID: 31424671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.